Research Forensic Library

A program of the Global Forensic and Justice Center at Florida International University

European Monitoring Centre for Drugs and Drug Addiction

TitleAuthorsSourceLinkYear
EU Drug Market: Methamphetamine — In-depth analysisEMCDDA and Europol; 56pp; 2022www.emcdda.europa.eu/publications/eu-drug-markets/methamphetamine_en2022
Recreational use of nitrous oxide: a growing concern for EuropeLeon Van Aerts, Joanna de Morais, Michael Evans-Brown, Rita Jorge, Ana Gallegos, Rachel Christie, Thomas Néfau, Gregorio Planchuelo, Roumen SedefovEMCDDA; 86pp; 2022www.emcdda.europa.eu/publications/rapid-communication/recreational-use-nitrous-oxide-growing-concern-europe_en2022
Complexity and differentiation of the MDMA retail market: insights from the European Web Survey on DrugsLies GremeauxEMCDDA; 2022www.emcdda.europa.eu/publications/insights/web-surveys/complexity-differentiation-mdma-retail-market-insights-european-web-survey-drugs_en2022
Comparing two approaches for estimating cannabis consumption: raking and regressionJonathan P. Caulkins, Kyle Furlong, Brandon McComas, Martha Nogueira Domingues, Aatir Siddique and Beau KilmerEMCDDA; 2022www.emcdda.europa.eu/publications/insights/web-surveys/comparing-approaches-estimating-cannabis-consumption-raking-regression_en2021
Sources of cannabis acquisition by country and frequency of use in the European web survey on drugsMike Vuolo and João MatiasEMCDDA; June 2022www.emcdda.europa.eu/publications/insights/web-surveys/sources-cannabis-acquisition-country-frequency-use-european-web-survey-drugs_en2022
New psychoactive substances: 25 years of early warning and response in Europe — an update from the EU Early Warning SystemEMCDDA; 38pp; June 2022www.emcdda.europa.eu/publications/rapid-communication/update-eu-early-warning-system-2022_en2022
New benzodiazepines in Europe – a reviewEMCDDA; 48pp; 2021www.emcdda.europa.eu/publications/rapid-communications/new-benzodiazepines-europe-review_en2021
3-CMC: Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)EMCDDA; 90pp; 2022www.emcdda.europa.eu/publications/risk-assessments/3-cmc_en2022
3-MMC: Report on the risk assessment of 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)EMCDDA; 2022www.emcdda.europa.eu/publications/risk-assessments/3-mmc_en2022
Methamphetamine from Afghanistan: signals indicate that Europe should be better preparedEuropean Monitoring Centre for Drugs and Drug Addiction; September 2021www.emcdda.europa.eu/system/files/publications/14071/EMCDDA-Methamphetamine-from-Afghanistan.pdf2021
Synthetic cannabinoids in Europe – a reviewV. Auwärter, J. de Morais, A. Gallegos, M. Evans-Brown, R. Christie, R. Jorge, R. SedefovEMCDDA; September 2021www.emcdda.europa.eu/system/files/publications/14035/Synthetic-cannabinoids-in-Europe-EMCDDA-technical-report.pdf2021
Global Forensic and Justice Center

11200 SW 8th Street
Miami, FL 33199
Contact Us